ARCHIVES

Supporters And A Critic Of Burzynski Comment

This article is from The Cancer Letter archive.

Vol. 24 No. 41 | October 30, 1998

Download PDF Visit The Full Archive

Related Articles

Cancer Panel: Lack Of Genetic Basis For Race Presents Dilemma For Studies; Data Collection Must Include Socioeconomic Measures, Report To Clinton Says

March 20, 1998

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

April 9, 2010

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

Bush Nominates Health Policy Advisor McClellan For FDA Commissioner

September 27, 2002

FDA Delays NDA On BCNU, But New Drug Seminar Still Scheduled

November 28, 1975

House Committee Probes NCI $5.2 Billion Sole-Source Contract With SAIC-Frederick.

November 14, 2008